SARS-CoV-2: Immunopeptidomics and Other Immunological Studies

Vaccines (Basel). 2022 Nov 21;10(11):1975. doi: 10.3390/vaccines10111975.

Authors

Vivek P Chavda¹, Elrashdy M Redwan^{2

3}

Affiliations

¹ Department of Pharmaceutics and Pharmaceutical Technology, L M College of Pharmacy, Ahmedabad 380008, India.
² Biological Science Department, Faculty of Science, King Abdulaziz University, P.O. Box 80203, Jeddah 21589, Saudi Arabia.
³ Protein Research Department, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications (SRTA City), Alexandria 21934, Egypt.

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has produced a significant continuing epidemic worldwide [...].

Publication types

Editorial

Grants and funding

Not applicable.